Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy Study of QR-333 in Patient's With Symptomatic Diabetic Neuropathy

ClinicalTrials.gov ID: NCT00568035

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00568035. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 2:58 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Study of QR-333 for the Treatment of Symptomatic Diabetic Peripheral Neuropathy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether QR-333 is safe and effective in the treatment of diabetic neuropathy as compared to placebo.

Study identification

NCT ID
NCT00568035
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Quigley Pharma, Inc.
Industry
Enrollment
140 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2006 (Type not available)
Primary completion
Nov 2008 (Actual)
Completion
Nov 2008 (Actual)
Last update posted
Jan 8, 2009

2006 – 2008

United States locations

U.S. sites
19
U.S. states
10
U.S. cities
17
Facility City State ZIP Site status
Parkway Medical Center Birmingham Alabama 35215 —
Seale Harris Clinic / Alliance Clinical Research Birmingham Alabama 35216 —
Pacific Sleep Medicine Services, Inc Fountain Valley California 92708 —
Advanced Medical Research, LLC Lakewood California 90712 —
Diablo Clinical Research, Inc. Walnut Creek California 94598 —
Renstar Medical Research Ocala Florida 34471 —
Baptist Clinical Research Pensacola Florida 35201 —
Stedman Clinical Trails Tampa Florida 33613 —
Metabolic Research Institute, Inc. West Palm Beach Florida 33401 —
A&A Pain Institute St Louis Missouri 63141 —
Rwjms/Umdnj New Brunswick New Jersey 08903 —
Land Clinical Studies West Caldwell New Jersey 07006 —
Kaleida Health, Diabetes Center of WNY Buffalo New York 14209 —
ECU Diabetes Research Center, Brody School of Medicine Greenville North Carolina 27834 —
Hartwell Research Group / Anderson Family Care Anderson South Carolina 29621 —
UT Southwestern Medical Center at Dallas Dallas Texas 75390 —
dgd Research San Antonio Texas 78229 —
Endeavor Clinical Trials, PA San Antonio Texas 78229 —
Rainier Clinical Research Center, Inc Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00568035, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 8, 2009 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.